Feb
03
Alembic Pharma Sees 4% Revenue Growth INR 138 Crore Profit in Q3FY25
3rd February 2025, Mumbai: Alembic Pharmaceuticals Limited reported its consolidated financial results for the third quarter ended 31st December, 2024. Financial Highlights Net Sales increased by 4% to Rs.1693 Crores. EBITDA up 1% to Rs. 271 Crores EBITDA Margin at 16% of Sales Net Profit at Rs.138 Crores Mr. Shaunak Amin, MD, Alembic Pharmaceuticals Limited […]